<DOC>
	<DOC>NCT01388907</DOC>
	<brief_summary>The purpose of this study was to evaluate clinically the efficacy of the PREVADH® Film in the prevention of adhesions in gynaecologic surgery, and to assess post-operative complications related to adhesions and pregnancy rate after myomectomy by open surgery.</brief_summary>
	<brief_title>Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery</brief_title>
	<detailed_description>This study was addressed to patients having an immediate or differed pregnancy desire and presenting a symptomatic or asymptomatic fibroma being able to interfere with fertility. - The primary end point was the assessment of adhesion rate to the uterine surgical sites during a laparoscopic second look performed 10 to 20 weeks post-surgery. - The secondary end points were the assessment, throughout a 3 years follow-up period, of: - pregnancy rate, - adverse events related to adhesions, - adnexal adhesions according to American Fertility Society score, - abdomino-pelvic adhesions according to the modified American Fertility Society score.</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Symptomatic(s) or asymptomatic(s) uterin(s) fibroma(s) being able to interfere with the fertility by the patient who having an immediate or differed desire of pregnancy. Size: diameter ≥ 6 cm at echographia (for the highest diameter) Location interstitial and / or subserosa planned laparotomic surgery negative pregnancy test within 48 hours of surgery signed inform consent History of abdominopelvic surgery (except appendicectomy cesarotomy) Preoperative embolization Endometriosis stage &gt;1 (American Fertility Society classification ≥ 5) Pregnant patient Diabetes Chronic corticotherapy / immunosupressor or immunomodulator drugs Previous analog LHRH drug therapy for the uterine myoma</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>myomectomy</keyword>
	<keyword>adhesion prevention</keyword>
	<keyword>pregnancy rate</keyword>
</DOC>